You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 289 No. 19, May 21, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  From the Centers for Disease Control and Prevention: Morbidity and Mortality Weekly Report
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Colon Cancer
 •Surgery
 •Surgical Interventions
 •Colorectal Surgery
 •Gastroenterology
 •Gastrointestinal Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Colorectal Cancer Test Use Among Persons Aged >=50 Years—United States, 2001

JAMA. 2003;289:2492-2493.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2003;52:193-196

1 table, 2 figures omitted

Colorectal cancer is the second leading cause of cancer-related death in the United States.1 The lifetime risk for having colorectal cancer diagnosed is 6%.2 Screening measures decrease the incidence and mortality of colorectal cancer by detecting early disease and removing precancerous lesions.3 The U.S. Preventive Services Task Force recommends routine cancer screening for U.S. adults aged >=50 years with one or a combination of the following screening options: annual home fecal occult blood testing (FOBT), sigmoidoscopy every 5 years, colonoscopy every 10 years, or double contrast barium enema every 5 years.3 To estimate rates and evaluate trends for colorectal cancer test use among U.S. adults aged >=50 years, CDC analyzed data from the 2001 Behavioral Risk Factor Surveillance System (BRFSS) on the use of FOBT and sigmoidoscopy/colonoscopy and compared the data for 2001 with those for 1997 and 1999. This report summarizes the . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening.
Zou et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:1115-1119.
ABSTRACT | FULL TEXT  

Family History Assessment to Detect Increased Risk for Colorectal Cancer: Conceptual Considerations and a Preliminary Economic Analysis
Ramsey et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:2494-2500.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.